News & Events

Fauci joins Georgetown faculty

April 18th, 2024

This summer, infectious diseases expert and advisor to seven presidents Anthony Fauci, M.D., joined the Georgetown faculty as a Distinguished University Professor, the university’s highest professional honor that recognizes extraordinary achievement in scholarship, teaching, and service.…

The curious brain

April 18th, 2024

From the time he was a young boy, fascinated with dinosaurs and his rock collection, Zac Colon (G’21) always felt drawn to the sciences. He liked understanding how organisms and systems worked—at one point even informing his parents he wanted to autopsy a dead squirrel.…

Blood pressure machine and cuff

Research Reveals How Aging Cells Can Be an Underlying Cause of Kidney Damage

December 8th, 2021

A study in mice by researchers at Georgetown Lombardi Comprehensive Cancer Center has found that stress and tissue damage initiated by angiotensin II, a molecule that is known to increase blood pressure and stiffening in the linings of blood vessels, leads to cellular senescence, a process by which a cell ages and permanently stops dividing but does not die. Importantly, when the researchers eliminated senescent cells from the mice, tissues returned to a normal state in spite of a continued infusion of angiotensin II.…

3D rendering of a natural killer cell destroying a cancer cell

Trial Stopped Early: Giving Immunotherapy Before Targeted Rx Improves Survival in Advanced Melanoma

November 15th, 2021

More people with advanced melanoma survive for two years or more when they receive a combination of two immunotherapy drugs given before a combination of two targeted therapies, if needed, compared to people who start treatment with targeted therapies. The finding comes from a clinical trial that was stopped early because definitive results became apparent sooner than expected. It provides strong evidence for how best to treat patients with melanoma that has a specific mutation: Immunotherapy is the better initial approach even for people whose tumors have a mutation that could be treated by targeted therapies.…

Colorful brain image

Vascular Defects Appear to Underlie the Progression of Parkinson’s Disease

November 12th, 2021

In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular defect in patients with moderately severe Parkinson’s disease. The finding could help explain an earlier outcome of the same study, in which the drug nilotinib was able to halt motor and nonmotor (cognition and quality of life) decline in the long term.…


Critical Period After Stroke Study (CPASS): A Phase II Clinical Trial Testing an Optimal Time for Motor Recovery After Stroke in Humans

September 20th, 2021

A phase II randomized clinical trial found that the optimal period for intensive rehabilitation of arm and hand use after a stroke should begin 60 to 90 days after the event. The study, conducted by Georgetown University and MedStar National Rehabilitation Network (NRH) researchers, was published September 20, 2021, in PNAS (Critical Period After Stroke Study (CPASS): A Phase II Clinical Trial Testing an Optimal Time for Motor Recovery After Stroke in Humans).…

Colorful brain image

Key Mental Abilities Can Actually Improve During Aging

August 19th, 2021

It’s long been believed that advancing age leads to broad declines in our mental abilities. Now, new research from Georgetown University Medical Center offers surprisingly good news by countering this view.…